Inhibition of DNA gyrase activity by Mycobacterium smegmatis MurI

被引:11
|
作者
Sengupta, Sugopa [1 ]
Nagaraja, Valakunja [1 ,2 ]
机构
[1] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India
[2] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India
关键词
Mycobacterium smegmatis; glutamate racemase; DNA gyrase; gyrase inhibitor; protein-protein interaction;
D O I
10.1111/j.1574-6968.2007.01005.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Glutamate racemase (MurI) catalyzes the interconversion of L-glutamate to D-glutamate, one of the essential amino acids present in the peptidoglycan. In addition to this essential enzymatic function, MurI from Escherichia coli, Bacillus subtilis and Mycobacterium tuberculosis inhibit DNA gyrase activity. A single gene for murI found in the Mycobacterium smegmatis genome was cloned and overexpressed in a homologous expression system to obtain a highly soluble enzyme. In addition to the racemization activity, M. smegmatis MurI inhibits DNA gyrase activity by preventing DNA binding of gyrase. The sequestration of the gyrase by MurI results in inhibition of all reactions catalyzed by DNA gyrase. More importantly, MurI overexpression in vivo in mycobacterial cells provides protection against the action of ciprofloxacin. The DNA gyrase-inhibitory property thus appears to be a typical characteristic of MurI and would have probably evolved to either modulate the function of the essential housekeeping enzyme or to provide protection to gyrase against gyrase inhibitors, which cause double-strand breaks in the genome.
引用
收藏
页码:40 / 47
页数:8
相关论文
共 50 条
  • [41] Thiol-modified gold nanoparticles for the inhibition of Mycobacterium smegmatis
    Gifford, Jennifer C.
    Bresee, Jamee
    Carter, Carly Jo
    Wang, Guankui
    Melander, Roberta J.
    Melander, Christian
    Feldheim, Daniel L.
    CHEMICAL COMMUNICATIONS, 2014, 50 (100) : 15860 - 15863
  • [42] Molecular mechanisms of drug inhibition of DNA gyrase
    Lewis, RJ
    Tsai, FTF
    Wigley, DB
    BIOESSAYS, 1996, 18 (08) : 661 - 671
  • [43] Growth inhibition of Mycobacterium smegmatis by mycobacteriophage-derived enzymes
    Grover, Navdeep
    Paskaleva, Elena E.
    Mehta, Krunal K.
    Dordick, Jonathan S.
    Kane, Ravi S.
    ENZYME AND MICROBIAL TECHNOLOGY, 2014, 63 : 1 - 6
  • [44] NONSPECIFIC IONIC INHIBITION OF ETHAMBUTOL BINDING BY MYCOBACTERIUM-SMEGMATIS
    BEGGS, WH
    ANDREWS, FA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 4 (02) : 115 - 119
  • [45] INHIBITION OF CELLULAR GLUTATHIONE BIOSYNTHESIS BY RIFAMPICIN IN MYCOBACTERIUM-SMEGMATIS
    KUMAR, S
    GANGULY, NK
    KOHLI, KK
    BIOCHEMISTRY INTERNATIONAL, 1992, 26 (03): : 469 - 476
  • [46] Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis
    Imai, Yu
    Hauk, Glenn
    Quigley, Jeffrey
    Liang, Libang
    Son, Sangkeun
    Ghiglieri, Meghan
    Gates, Michael F.
    Morrissette, Madeleine
    Shahsavari, Negar
    Niles, Samantha
    Baldisseri, Donna
    Honrao, Chandrashekhar
    Ma, Xiaoyu
    Guo, Jason J.
    Berger, James M.
    Lewis, Kim
    NATURE CHEMICAL BIOLOGY, 2022, 18 (11) : 1236 - +
  • [47] ALKALINE-PHOSPHATASE ACTIVITY IN MYCOBACTERIUM-SMEGMATIS
    AHMED, N
    TYAGI, AK
    PADH, H
    VENKITASUBRAMANIAN, TA
    INDIAN JOURNAL OF CHEST DISEASES & ALLIED SCIENCES, 1978, 20 (01): : 11 - 20
  • [48] TRANSPOSITIONAL ACTIVITY OF IS986 IN MYCOBACTERIUM-SMEGMATIS
    FOMUKONG, NG
    DALE, JW
    GENE, 1993, 130 (01) : 99 - 105
  • [49] Characterization and regulation of inositol monophosphatase activity in Mycobacterium smegmatis
    Nigou, J
    Besra, GS
    BIOCHEMICAL JOURNAL, 2002, 361 : 385 - 390
  • [50] DNA-GYRASE INHIBITION AND ANTIBACTERIAL ACTIVITY OF FLUOROQUINOLONES - INFLUENCE OF THE POSITION OF THE FLUORINE(S)
    CLAIREFOND, P
    BOUZARD, D
    LEDOUSSAL, B
    CORONEOS, E
    BAZILE, S
    MOREAU, N
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (07) : 643 - 646